Donor Blood Components Market Size, Share, and Forecast by 2031
Donor Blood Components Market: Size and Share
-
CAGR (2025 - 2031)5.7% -
Market Size 2024
US$ 10.08 Billion -
Market Size
US$ 14.65 Billion in 2031

Market Dynamics
- Rising Prevalence of Cancer and Immunosuppressive Diseases
- Increasing Donor Awareness
- Rising Demand for Plasma-Derived Therapies
- Emerging Market Demand
Market Segmentation

- Red Blood Cells
- White blood cells
- Platelets
- Plasma
- Others

- Immunosuppression
- Oncology

- Anemia management
- Thrombocytopenia treatment
- Coagulopathy correction
- Supportive care during chemotherapy
- Surgery
- Others

- Adult
- Child
Donor Blood Components Market Players Density: Understanding Its Impact on Business Dynamics
The Donor Blood Components Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Donor Blood Components Market are:
- Roswell Park Comprehensive Cancer Center
- Policlinico of Milan
- Vitalant
- MD Anderson Cancer Center
- The Johns Hopkins Hospital
- The Royal Marsden
Disclaimer: The companies listed above are not ranked in any particular order.

- Get the Donor Blood Components Market top key players overview